A Single Dose of the Selective Serotonin Reuptake Inhibitor Citalopram Exacerbates Anxiety in Humans: A Fear-Potentiated Startle Study
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
Serotonin reuptake inhibitors may increase symptoms of anxiety immediately following treatment initiation. The present study examined whether acute citalopram increased fear-potentiated startle to predictable and/or unpredictable shocks in healthy subjects. Eighteen healthy subjects each received two treatments, placebo and 20 mg citalopram in a crossover design. Participants were exposed to three conditions including one in which predictable aversive shocks were signaled by a cue, a second in which unpredictable shocks were anticipated, and a third in which no shocks were administered. Changes in aversive states were investigated using acoustic startle stimuli. Citalopram did not affect baseline startle. However, the phasic startle potentiation to the threat cue in the predictable condition was robustly increased by acute citalopram. The sustained startle potentiation in the unpredictable conditions was also increased by citalopram, but only when the drug was given during the first session. These results indicate that a single dose of citalopram is not anxiogenic in itself, but can exacerbate the expression of fear and anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although acute citalopram increased both fear and anxiety to predictable and unpredictable shock, respectively (Grillon et al, 2007)”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Grillon et al, 2007
In the citing paper
“Seven days' treatment with citalopram, but not reboxetine, reduced the emotion-potentiated startle,25 and in line with clinical experience and effects on fearful face recognition, a single dose of citalopram potentiates this startle response.59”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [59]
In the citing paper
“Following both single doses of citalopram (reflecting possible early anxiogenic responses)28,59 and acute tryptophan depletion75 negative changes in emotional processing can be measured in healthy volunteer models”
From The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment (2015) · cites this paper as [59]
Citations
Cites
(1970) · Cited by 24,983
Conscious and unconscious emotional learning in the human amygdala
Morris, J. S., Öhman, A., & Dolan, R. J. (1998) · Nature · doi:10.1038/30976 · Cited by 1,665 · cited 1×
“This would be consistent with findings that the amygdala can be activated without alteration in conscious mood (Morris et al, 1998).”
ResultClassical fear-conditioning in the anxiety disorders: a meta-analysis
Lissek, S., Powers, A. S., McClure, E. B., Phelps, E. A., Woldehawariat, G., Grillon, C., & Pine, D. S. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.10.007 · Cited by 1,034 · cited 1×
“…Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org dure was implemented instead of a conditioning procedure given that abnormal responses to verbal threat more consistently characterize clinical anxiety states, relative to conditioning procedure (Lissek et al, 2005a, b).”
MethodSelf-citationRole of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838 · cited 8×
“The amygdala is also involved in the initiation of sustained aversive responses (Walker et al, 2003).”
BackgroundMethodInfluentialGrillon, C., & Baas, J. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00202-5 · Cited by 563 · cited 1×
“Moreover, this design focuses on modulatory influences on expressions of aversive responses rather than learning and memory processes inherently associated with associative learning procedures (Grillon and Baas, 2003).”
BackgroundSelf-citationAutoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537 · cited 4×
“The initially anxiogenic-like effects may result from an acute increased availability of serotonin on inhibitory 5HT1A autoreceptors, leading to a reduced firing of ascending serotonin raphe neurons, until adaptive changes ensue following chronic treatment (Piñeyro and Blier, 1999).”
BackgroundInfluentialFear‐Potentiated Startle in Humans: Effects of Anticipatory Anxiety on the Acoustic Blink Reflex
Grillon, C., AMELI, R., Woods, S. W., Merikangas, K., & Davis, M. (1991) · Psychophysiology · doi:10.1111/j.1469-8986.1991.tb01999.x · Cited by 462 · cited 1×
“Prior studies with this paradigm show that threat cues are very easy to discriminate from safe cues (Grillon et al, 1991).”
BackgroundSelf-citationAcute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers
Harmer, C. J., Bhagwagar, Z., Perrett, D. I., Völlm, B. A., Cowen, P. J., & Goodwin, G. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300004 · Cited by 420 · cited 7×
“This effect is consistent with clinical reports of symptom exacerbation following treatment initiation (Gorman et al, 1987; Ramos et al, 1993) and with evidence of facilitation of processing threat cues in experimental models following acute SSRIs (Burghardt et al, 2004; Harmer et al, 2003b).”
BackgroundResultInfluentialAnxious Responses to Predictable and Unpredictable Aversive Events.
Grillon, C., Baas, J. P., Lissek, S., Smith, K., & Milstein, J. (2004) · Behavioral Neuroscience · doi:10.1037/0735-7044.118.5.916 · Cited by 349 · cited 2×
“…two threat responses: a phasic fear-potentiated startle response associated with a cue and a more sustained startle potentiation generated by less explicit threat (Grillon et al, 2005, 2004) by administering predictable (ie signaled by a cue) or unpredictable (ie unsignaled) shocks, respectively.”
BackgroundResultSelf-citationSánchez, C., & Meier, E. (1997) · Psychopharmacology · doi:10.1007/s002130050181 · Cited by 255 · cited 1×
“In animals, acute serotonin can increase (Bagdy et al, 2001; Griebel et al, 1994) or decrease (Inoue et al, 1996, 2004; Sanchez and Meier, 1997) anxiety-like responses, depending on the model used.”
Background
Research works printed but not linked: 3
- First MB, Spitzer RI, Williams JBW, Gibbon M (1995). Structured Clinical Interview for DSM-V (SCID). American Psychiatric Association: Washington, DC.
- Phelps EA, O'Connor KJ, Gatenby JC, Anderson AK, Grillon C, Davis M et al (1998). Activation of the human amygdala by a cognitive representation of fear: an FMRI study. Soc Neurosci Abstr 24: 1524.
- Vertes RP, Fortin WJ, Crane AM (1999). Projections of the median raphe nucleus in the rat. J Comp Neurol 407: 555–582. · DOI · Paper page
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Self-citationHarmer, C. J., Goodwin, G. M., & Cowen, P. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051193 · Cited by 542
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Schmitz, A., & Grillon, C. (2012) · Nature Protocols · doi:10.1038/nprot.2012.001 · Cited by 383
Self-citationGrillon, C., Lissek, S., Rabin, S., McDowell, D., Dvir, S., & Pine, D. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101581 · Cited by 300
“Both the large fear-potentiated startle response to the threat cue (15, 20, 21) and the similar degree of potentiation across groups replicate previous findings (13, 14).”
MethodResultSelf-citationAndrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281
“In healthy volunteers, a single dose of the SSRI citalopram potentiates anxiety, while chronic treatment inhibits it (Grillon et al., 2007, 2009).”
BackgroundGrillon, C., Pine, D. S., Lissek, S., Rabin, S., Bonne, O., & Vythilingam, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.028 · Cited by 272
Self-citationKnoll, A. T., Meloni, E. G., Thomas, J. B., Carroll, F. I., & Carlezon, W. A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127415 · Cited by 225
“However, antidepressants are associated with delayed therapeutic efficacy, and SSRIs often exacerbate anxiety in humans (Catalano et al., 2000; Grillon et al., 2007) as well as in rodent models of fear and anxiety (Griebel et al.”
BackgroundResultInfluentialSerotonin and emotional processing: does it help explain antidepressant drug action?
Harmer, C. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.036 · Cited by 219
Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis
Daniel, S. E., & Rainnie, D. G. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.178 · Cited by 213
“…and there is an acute effect of SSRI treatment associated with an exacerbation of the expression of fear and anxiety behavior in animals and humans (Burghardt et al, 2004; Grillon et al, 2007; for a review on the effect of SSRIs on fear conditioning in rodents, see Burghardt and Bauer, 2013).”
BackgroundSerotonin, Amygdala and Fear: Assembling the Puzzle
Bocchio, M., McHugh, S. B., Bannerman, D. M., Sharp, T., & Capogna, M. (2016) · Frontiers in Neural Circuits · doi:10.3389/fncir.2016.00024 · Cited by 202
“In humans, citalopram administration (20 mg) 2–3 h before acquisition increases fear-potentiated startle (Browning et al., 2007; Grillon et al., 2007).”
BackgroundPaumier, K. L., Sukoff Rizzo, S. J., Berger, Z., Chen, Y., Gonzales, C., Kaftan, E., Li, L., Lotarski, S., Monaghan, M., Shen, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070274 · Cited by 192
“However, attenuation of the acoustic startle response may be indicative of an anxiolytic-like effect as startle is exacerbated with anxiogenics [59,60] and attenuated with anxiolytics [61,62], thus suggesting A53T mice develop an anxiolytic phenotype with age.”
BackgroundAnderberg, R. H., Richard, J. E., Hansson, C., Nissbrandt, H., Bergquist, F., & Skibicka, K. P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.021 · Cited by 170
Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine
Liu, J., Garza, J. C., Bronner, J., Kim, C. S., Zhang, W., & Lu, X.-Y. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1684-3 · Cited by 163
“However, these SSRIs can worsen anxiety in the initial phase of the treatment (Den Boer and Westenberg 1990; den Boer et al. 1987; Gorman et al. 1987; Grillon et al. 2007; Jick et al. 2004).”
Bowers, M. E., & Ressler, K. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.008 · Cited by 145
“Several studies find increased cued fear acquisition and expression in rodents and humans with acute SSRI administration (24-26).”
O’Donovan, A., Slavich, G. M., Epel, E. S., & Neylan, T. C. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.013 · Cited by 146
“Although singledose administration of selective serotonin reuptake inhibitors (SSRIs) may increase threat sensitivity (Browning et al., 2007; Grillon et al., 2007), longer term administration of commonly used psychopharmacological agents including SSRIs and selective noradrenaline reuptake inhibitors may reduce threat…”
A cognitive neuropsychological model of antidepressant drug action
Pringle, A., Browning, M., Cowen, P. J., & Harmer, C. J. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.022 · Cited by 130
Vaidyanathan, U., Patrick, C. J., & Cuthbert, B. N. (2009) · Psychological Bulletin · doi:10.1037/a0017222 · Cited by 129
Serotonin in fear conditioning processes
Bauer, E. P. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.028 · Cited by 151
Dekeyne, A., la Cour, C. M., Gobert, A., Brocco, M., Lejeune, F., Serres, F., Sharp, T., Daszuta, A., Soumier, A., Papp, M., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1177-9 · Cited by 135
“effect, mirroring clinical observations of short- and longterm exacerbation and relief of anxious symptoms, respectively (File and Seth 2003; Grillon et al. 2007; Millan 2003, 2006).”
BackgroundEfficacy markers in depression
Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367722 · Cited by 122
“In line with anxiogenic-like effects of acute citalopram seen in fear recognition above, a single dose of this SSRI increased startle reactivity in this paradigm (Browning et al., 2007; Grillon et al., 2007) whereas repeated administration decreased the emotion potentiated startle response (Harmer et al.”
BackgroundRobinson, O. J., Letkiewicz, A. M., Overstreet, C., Ernst, M., & Grillon, C. (2011) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-011-0030-5 · Cited by 114
Self-citationMeulders, A., Jans, A., & Vlaeyen, J. W. S. (2015) · Pain · doi:10.1016/j.pain.0000000000000016 · Cited by 110
“This study used a convenience sample of 48 female participants including 2 age-matched diagnostic groups: 24 FM patients (mean 6 SD [range] age 5 39 6 13 [19-60] years) and 24 HC (mean6 SD [range] age5 386 13 [18-61] years).”
MethodHammack, S. E., Guo, J.-D., Hazra, R., Dabrowska, J., Myers, K. M., & Rainnie, D. G. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.05.013 · Cited by 103
“…treatment of anxiety disorders, produce therapeutic reductions in anxiety only after several weeks of treatment, and yet the acute effects of SSRI treatment often are associated with increases in anxiety-like behavior in both humans and animals alike (Burghardt et al., 2004; Grillon et al., 2007).”
BackgroundBurghardt, N. S., & Bauer, E. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.050 · Cited by 125
Baldwin, D. S., Florea, I., Jacobsen, P. L., Zhong, W., & Nomikos, G. G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.015 · Cited by 93
“In addition, listings of TEAEs were manually reviewed for potential anxiogenic effects related to the initiation of vortioxetine, as emergent anxiety has been reported in several studies of antidepressants after treatment initiation (Gollan et al., 2012; Grillon et al., 2007; Li et al., 2011).”
BackgroundGrillon, C., Chavis, C., Covington, M. F., & Pine, D. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.141 · Cited by 88
“Regardless, it should be noted that, consistent with the clinical observation that SSRIs can be anxiogenic in patients following initial treatment, we reported an increase in cued fear and contextual anxiety in a similar study using a single 20-mg dose of citalopram (Grillon et al, 2007).”
Self-citationMedian raphe serotonin neurons promote anxiety-like behavior via inputs to the dorsal hippocampus
Abela, A. R., Browne, C. J., Sargin, D., Prévot, T. D., Ji, X. D., Li, Z., Lambe, E. K., & Fletcher, P. J. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107985 · Cited by 105
Simmons, A. N., Arce, E., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2009) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990149 · Cited by 80
“Acute doses of SSRI treatment can increase anxiety (Bagdy et al. 2001; Greenwood et al. 2008; Grillon et al. 2007) whereas prolonged administration can attenuate amygdala activation (Harmer et al.”
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
Steiner, M. A., Lecourt, H., & Jenck, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2736-7 · Cited by 83
“However, SSRIs sometimes exacerbate symptoms of conditioned fear upon acute treatment both in humans (Grillon et al. 2007) and rats (Burghardt et al.”
Yildirim, B. O., & Derksen, J. J. L. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.009 · Cited by 90
Meulders, A., Meulders, M., Stouten, I., Bie, J. D., & Vlaeyen, J. W. S. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.10.004 · Cited by 93
Early effects of mirtazapine on emotional processing
Arnone, D., Horder, J., Cowen, P. J., & Harmer, C. J. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1410-6 · Cited by 74
“D. Arnone Neuroscience and Psychiatry Unit, University of Manchester, Manchester, UK startle responses in the emotion potentiated startle paradigm (Browning et al 2007, Grillon et al. 2005) and enhanced fearful facial expression recognition (Harmer et al 2003a, Browning et al 2007).”
BackgroundSerotonin circuits and anxiety: what can invertebrates teach us?
Curran, K. P., & Chalasani, S. H. (2012) · Invertebrate Neuroscience · doi:10.1007/s10158-012-0140-y · Cited by 96
“In the first century AD, patients suffering from anxiety were sedated using opium (Shorter 1997).”
MethodDifferential effects of acute and repeated citalopram in mouse models of anxiety and depression
Mombereau, C., Gur, T. L., Onksen, J., & Blendy, J. A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990630 · Cited by 73
“In healthy volunteers, acute administration of citalopram precipitates anxiety using fear-potentiated startle as the measure of the anxious state, while chronic administration of citalopram decreases aversive states (Grillon et al. 2007, 2008).”
Carr, G. V., & Lucki, I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1832-9 · Cited by 70
“In fact, treatment with antidepressants can often induce or exacerbate anxiety before therapeutic effects have had an opportunity to emerge (Grillon et al. 2007; Marshall et al. 1995; Zinner 1994).”
Harmer, C. J., Heinzen, J., O’Sullivan, U., Ayres, R. A., & Cowen, P. J. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1058-7 · Cited by 69
“However, unlike reboxetine, acute administration of citalopram also increased fear processing seen as exaggerated startle responses in the emotionpotentiated startle paradigm (Browning et al. 2007; Grillon et al. 2007) and enhanced fearful facial expression recognition (Harmer et al.”
BackgroundResultSerotonin transporter polymorphisms (5-HTTLPR) in emotion processing
Jonassen, R., & Landrø, N. I. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.003 · Cited by 67
Pringle, A., & Harmer, C. J. (2015) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2015.17.4/apringle · Cited by 61
McDevitt, R. A., Hiroi, R., Mackenzie, S. M., Robin, N. C., Cohn, A., Kim, J. J., & Neumaier, J. F. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.029 · Cited by 60
Ravinder, S., Burghardt, N. S., Brodsky, R., Bauer, E. P., & Chattarji, S. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.137 · Cited by 59
“Furthermore, there are reports that acute administration of SSRIs increase amygdala activity(56,57) and fear-potentiated startle responses in healthy humans.(58) Although this work implicates the amygdala in the acute anxiogenic effects of SSRIs, the key unresolved issue was to”
BackgroundIf or when? Uncertainty's role in anxious anticipation
Bennett, K. P., Sinclair, J. V., & Larson, C. L. (2018) · Psychophysiology · doi:10.1111/psyp.13066 · Cited by 58
Selvaraj, S., Walker, C., Arnone, D., Cao, B., Faulkner, P., Cowen, P. J., Roiser, J. P., & Howes, O. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.166 · Cited by 58
“The administration of single doses of citalopram, a commonly used SSRI, in healthy human subjects is associated with enhanced startle responses and fear recognition (Browning et al, 2007; Burghardt et al, 2004; Grillon et al, 2007) and altered serotonin release (Selvaraj et al, 2012b).”
BackgroundThe Role of Serotonin in Fear Learning and Memory: A Systematic Review of Human Studies
Tortora, F., Hadipour, A. L., Battaglia, S., Falzone, A., Avenanti, A., & Vicario, C. M. (2023) · Brain Sciences · doi:10.3390/brainsci13081197 · Cited by 66
Lebrón‐Milad, K., Tsareva, A., Ahmed, N., & Milad, M. R. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.024 · Cited by 66
Johnson, P. L., Molosh, A., Fitz, S. D., Arendt, D., Deehan, G. A., Federici, L. M., Bernabe, C., Engleman, E. A., Rodd, Z. A., Lowry, C. A., et al. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.09.021 · Cited by 56
“Acute treatment with SSRIs also enhances fear-potentiated startle in humans (Grillon et al., 2007).”
BackgroundGrillon, C., & Ernst, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.024 · Cited by 52
Self-citationThompson, B. J., Jessen, T. N., Henry, L. K., Field, J. R., Gamble, K. L., Gresch, P. J., Carneiro, A. M. D., Horton, R. E., Chisnell, P. J., Belova, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011920108 · Cited by 63
“It is interesting to speculate that the enhanced immobility produced by SSRIs in our model may reflect the anxiogenic nature experienced by human subjects within the first few days of SSRI administration (50, 51), that, if validated, presents a novel paradigm to identify medications that can ameliorate this undesirabl…”
BackgroundAllan, N. P., Gorka, S. M., Saulnier, K. G., & Bryan, C. J. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01413-z · Cited by 66
Attentional bias in untreated panic disorder
Reinecke, A., Cooper, M., Favaron, E., Massey-Chase, R. A., & Harmer, C. J. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.07.020 · Cited by 70
“Bycontrast, acute administrationof SSRIs (Harmer et al., 2003a; Browning et al., 2007; Grillon et al., 2007) appears to increase threat relevant processing across a number of paradigms, consistent with reports of increased anxiety early on in treatment with SSRIs (Kent et al., 1998).”
InfluentialSerotonergic Modulation of Conditioned Fear
Homberg, J. R. (2012) · Scientifica · doi:10.6064/2012/821549 · Cited by 58
“Regarding fear expression, as measured by CS or context exposure during the memory retrieval test, it was found that acute citalopram treatment did not alter baseline responding but signi�cantly increased cued fear-potentiated startle, whereas the effect of acute citalopram on sustained (context-induced) fear was mild…”
MethodInoue, T., Kitaichi, Y., & Koyama, T. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.09.002 · Cited by 56
Greater sustained anxiety but not phasic fear in women compared to men.
Grillon, C. (2008) · Emotion · doi:10.1037/1528-3542.8.3.410 · Cited by 49
Self-citationThe CRH1 Antagonist GSK561679 Increases Human Fear But Not Anxiety as Assessed by Startle
Grillon, C., Hale, E., Lieberman, L., Davis, A., Pine, D. S., & Ernst, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.316 · Cited by 49
Self-citationKlumpers, F., Heitland, I., Oosting, R. S., Kenemans, J. L., & Baas, J. M. P. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.10.018 · Cited by 53
Context conditioning in humans using commercially available immersive Virtual Reality
Kroes, M. C. W., Dunsmoor, J. E., Mackey, W. E., McClay, M., & Phelps, E. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-08184-7 · Cited by 59
The Role of the Amygdala in Anxiety Disorders
L., G., M., A., L., J., & J., M. (2012) · The Amygdala - A Discrete Multitasking Manager · doi:10.5772/50323 · Cited by 45
Klein, R. G. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.02061.x · Cited by 70
Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals
Bui, E., Orr, S. P., Jacoby, R. J., Keshaviah, A., LeBlanc, N. J., Milad, M. R., Pollack, M. H., & Simon, N. M. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2330 · Cited by 42
“, 2004), as did Grillon, Levenson and Pine (Grillon et al., 2007) when citalopram was administered as a single 20mg dose to humans.”
ResultGrillon, C., Heller, R., Hirschhorn, E., Kling, M. A., Pine, D. S., Schulkin, J., & Vythilingam, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.013 · Cited by 41
“However, this sample size is similar to or greater than that of our previous psychopharmacological studies (29,30,51).”
ResultSelf-citationA single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women
Jonassen, R., Chelnokova, O., Harmer, C., Leknes, S., & Landrø, N. I. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3729-5 · Cited by 39
Pringle, A., McCabe, C., Cowen, P., & Harmer, C. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112474523 · Cited by 37
“Similarly, the emotion-potentiated startle, which can be conceptualised as the human analogue of the rodent fear-potentiated startle, reveals effects of citalopram (Browning et al., 2007; Grillon et al., 2007; Harmer et al., 2004), but not of reboxetine (Harmer et al.”
BackgroundResultInfluentialBosker, F. J., Tanke, M. A. C., Jongsma, M. E., Cremers, T. I. F. H., Jagtman, E., Pietersen, C. Y., van der Hart, M. G. C., Gladkevich, A. V., Kema, I. P., Westerink, B. H. C., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.001 · Cited by 40
“In humans, the effects of a single dose of citalopram converged to an increased ASR, but without any clear effect on habituation (Liechti et al., 2001; Grillon et al., 2007).”
Godlewska, B. R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.12.010 · Cited by 42
Baas, J. M. P., & Heitland, I. (2014) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2014.10.016 · Cited by 38
Tomasi, J., Lisoway, A. J., Zai, C. C. H., Harripaul, R., Müller, D. J., Zai, G. C., McCabe, R. E., Richter, M. A., Kennedy, J. L., & Tiwari, A. K. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.09.002 · Cited by 47
Lago, T. R., Brownstein, M., Page, E., Beydler, E. M., Manbeck, A. B., Beale, A. M., Roberts, C., Balderston, N. L., Damiano, E. M., Pineles, S. L., et al. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05861-4 · Cited by 38
Self-citationMcEuen, J. G., Semsar, K. A., Lim, M. A., & Bale, T. L. (2009) · Endocrinology · doi:10.1210/en.2008-1721 · Cited by 36
“Although chronic citalopram failed to induce significant drug effects, trends in data suggesting a reduced HPA response after chronic SSRI exposure may indicate a potential blunting of the HPA and suggest a potential measure for therapeutic effects of chronic SSRI (53, 64).”
BackgroundRobinson, O. J., Overstreet, C., Allen, P. S., Pine, D. S., & Grillon, C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.43 · Cited by 35
Self-citationGrillon, C., Franco-Chaves, J. A., Mateus, C. F., Ionescu, D. F., & Zarate, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070969 · Cited by 35
“The procedure is described in details in a methodology article [29] and was similar to that of recent investigations testing the effect of anxiolytics on startle potentiation during shocks anticipation [36,37].”
Self-citationSerotonin depletion impairs both Pavlovian and instrumental reversal learning in healthy humans
Kanen, J. W., Apergis-Schoute, A. M., Yellowlees, R., Arntz, F. E., van der Flier, F. E., Price, A., Cardinal, R. N., Christmas, D. M., Clark, L., Sahakian, B. J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01240-9 · Cited by 34
Labuschagne, I., Croft, R. J., Phan, K., & Nathan, P. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108097878 · Cited by 38
Depressed mood enhances anxiety to unpredictable threat
Robinson, O. J., Overstreet, C., Letkiewicz, A., & Grillon, C. (2012) · Psychological Medicine · doi:10.1017/s0033291711002583 · Cited by 32
“As expected (Grillon et al. 2006), startle magnitude during ITI was larger in the U compared to the N condition (Table 3), resulting in a condition main effect (F1,34=111.”
ResultSelf-citationSantangelo, A. M., Ito, M., Shiba, Y., Clarke, H. F., Schut, E. H. S., Cockcroft, G. J., Ferguson‐Smith, A. C., & Roberts, A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.41 · Cited by 34
Walsh, A. E. L., Huneke, N. T. M., Brown, R. E., Browning, M. D., Cowen, P. J., & Harmer, C. J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00482 · Cited by 34
Grillon, C., Avenevoli, S., Daurignac, E. C., & Merikangas, K. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.027 · Cited by 36
Self-citationPattern of distribution of serotonergic fibers to the amygdala and extended amygdala in the rat
Linley, S. B., Olucha-Bordonau, F. E., & Vertes, R. P. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24044 · Cited by 33
NK 1 receptor antagonism and emotional processing in healthy volunteers
Chandra, P., Hafizi, S., Massey-Chase, R., Goodwin, G., Cowen, P., & Harmer, C. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109103101 · Cited by 30
Kaye, J. T., Bradford, D. E., Magruder, K. P., & Curtin, J. J. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.353 · Cited by 31
“Specifically, acute administration of SSRIs is anxiogenic and increases startle potentiation to unpredictable threat (Grillon et al., 2007b), whereas chronic administration is anxiolytic and decreases startle potentiation to unpredictable threat (Grillon et al., 2009).”
BackgroundHensler, J. G. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70090-4 · Cited by 42
Muraki, I., Inoue, T., & Koyama, T. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.040 · Cited by 30
“Acute citalopram increased the fear related response in healthy subjects, but was not anxiogenic in the absence of danger (Grillon et al., 2007).”
BackgroundResultFlexible attention deployment in threatening contexts: An instructed fear conditioning study.
Shechner, T., Pelc, T., Pine, D. S., Fox, N. A., & Bar-Haim, Y. (2012) · Emotion · doi:10.1037/a0027072 · Cited by 28
“This argument receives additional support from Grillon, Baas, Cornwell, and Johnson (2006) and Grillon, Levenson, and Pine (2007), who show greater physiological responding to instructed than uninstructed conditioning paradigms.”
Self-citationRisbrough, V. B., Glenn, D. E., & Baker, D. G. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5010 · Cited by 30
“…validity for SSRI effects in patients is that acute SSRI treatment potentiates fear expression in conditioned fear models, similar to accounts of increased anxiety symptoms in patients in the initial phase of SSRI treatment (Garcia-Leal et al. 2010; Grillon et al. 2007; Silva et al. 2001).”
ResultMorriss, J., Biagi, N., & Dodd, H. F. (2020) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2020.07.009 · Cited by 29
Anxiety and depression after breast cancer: The predictive role of monoamine levels
Pérez-Tejada, J., Labaka, A., Vegas, Ó., Larraioz, A., Pescador, A., & Arregi, A. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.101953 · Cited by 37
Acute fluoxetine modulates emotional processing in young adult volunteers
Capitão, L. P., Murphy, S. E., Browning, M. D., Cowen, P. J., & Harmer, C. J. (2015) · Psychological Medicine · doi:10.1017/s0033291715000240 · Cited by 34
“…dose of the SSRI citalopram increases the processing of threat-related stimuli, as reflected by an increased recognition of fearful facial expressions (Harmer et al. 2003a; Browning et al. 2007) and higher emotional reactivity in the startle paradigm (Browning et al. 2007; Grillon et al. 2007).”
BackgroundThe effect of SSRIs on fear learning: a systematic review and meta-analysis
Heesbeen, E. J., Bijlsma, E. Y., Verdouw, P. M., Lissa, C. J. V., Hooijmans, C. R., & Groenink, L. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06333-7 · Cited by 31
Hestermann, D., Temel, Y., Blokland, A., & Lim, L. W. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.003 · Cited by 28
“However, many studies have reported that treatment with acute SSRIs (fluoxetine, citalopram, sertraline, paroxetine) produced anxiety symptoms [6, 38, 39].”
Harmer, C. J., Dawson, G. R., Dourish, C. T., Favaron, E., Parsons, E., Fiore, M., Zucchetto, M., Bifone, A., Poggesi, I., Fernandes, S., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112472558 · Cited by 24
“…of citalopram would be expected to facilitate the recognition of both positive and threat relevant facial expressions and increase startle responses in the emotion potentiated startle paradigm, similar to previous studies (Browning et al., 2007; Grillon et al., 2007; Harmer et al., 2003a).”
ResultGarcia-Leal, C., Del‐Ben, C. M., Leal, F. M., Graeff, F. G., & Guimarães, F. S. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108101782 · Cited by 29
“In the same direction, citalopram increased the anxiety provoked by a startle reflex paradigm, but only during the stressful phases of the task (Grillon et al., 2007).”
Background(2021) · doi:10.1016/j.bpsc.2020.12.012 · Cited by 23
Pringle, A., Parsons, E., Cowen, L., McTavish, S., Cowen, P., & Harmer, C. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112446535 · Cited by 21
“SSRI treatments have been reported to initially increase the emotion-potentiated startle effect with acute administration but this effect was reversed after seven daily treatments (Browning et al., 2007; Grillon et al., 2007; Harmer et al., 2004).”
BackgroundBaas, J. M. P., Mol, N., Kenemans, J. L., Prinssen, E. P. M., Niklson, I. A., Xia-Chen, C., Broeyer, F. J. F., & van Gerven, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1516-5 · Cited by 26
“…results were rather similar in pattern to the effects on startle (significant reduction in overall startle/fearfulness with a marginally significant interaction with context), while usually, the FPS measures prove more sensitive than subjective ratings (Grillon et al. 2006; Grillon et al. 2007).”
ResultShort-term NK1 receptor antagonism and emotional processing in healthy volunteers
Pringle, A., McTavish, S. F., Williams, C., Smith, R., Cowen, P. J., & Harmer, C. J. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2133-z · Cited by 18
“This is of particular interest as previous studies suggest that the effects of antidepressant treatment may vary according to duration of treatment, such that increased startle responses and fear recognition (indicative of an anxiogenic-like response) are reported following acute doses of citalopram (Browning et al. 2…”
BackgroundHoeffer, C. A., Wong, H., Cain, P., Levenga, J., Cowansage, K. K., Choi, Y. Y., Davy, C., Majmundar, N. J., McMillan, D. R., Rothermel, B. A., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3513-12.2013 · Cited by 18
Serotoninergic effects on judgments and social learning of trustworthiness
Simonsen, A., Scheel‐Krüger, J., Jensen, M., Roepstorff, A., Møller, A., Frith, C., & Campbell-Meiklejohn, D. K. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3444-2 · Cited by 19
“Correspondingly, acute SSRI treatment can enhance processing of threat (Garcia-Leal et al. 2010), manifested as increased recognition of fear in faces (Browning et al. 2007; Harmer et al. 2003) and potentiated startle responses (Browning et al. 2007; Grillon et al. 2007) in healthy volunteers.”
BackgroundKappa opioid receptors mediate where fear is expressed following extinction training
Cole, S., Richardson, R., & McNally, G. P. (2011) · Learning & Memory · doi:10.1101/lm.2049511 · Cited by 19
“These dual anxiolytic and anti-depressant properties of nor-BNI are of note considering standard antidepressants can induce anxiety in humans (Grillon et al. 2007).”
BackgroundExercise decreases defensive responses to unpredictable, but not predictable, threat
Lago, T. R., Hsiung, A., Leitner, B. P., Duckworth, C. J., Chen, K. Y., Ernst, M., & Grillon, C. (2018) · Depression and Anxiety · doi:10.1002/da.22748 · Cited by 15
“…Nelson, Sarapas, et al., 2013; Gorka, Nelson & Shankman, 2013; Gorka et al., 2015; Gorka et al., 2017; Gorka, Lieberman, Phan, & Shankman, 2016; Grillon et al., 1998; Grillon, Baas, Pine, et al., 2006; Grillon, Pine, Baas, et al., 2006; Grillon, Chavis, Covington, et al., 2009; Grillon, Pine,…”
BackgroundSelf-citationKarakaya, M., Scaramuzzi, A., Macrì, S., & Porfiri, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110172 · Cited by 14
Greenfield, M. S., Wang, Y., & Msghina, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.988893 · Cited by 15
Metadata
- Authors
- Grillon, C., Levenson, J., & Pine, D. S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Grillon, Christian
- Venue
- Neuropsychopharmacology
- Published
- 2006-09-13
- Volume
- 32
- Issue
- 1
- Pages
- 225-231
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2030071660
- Cited by
- 162
- References
- 36
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 6 · 2023: 10 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 6 · 2015: 15 · 2014: 10 · 2013: 11 · 2012: 11
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- citalopram, selective serotonin reuptake inhibitors, anxiogenic effects, fear potentiation, acoustic startle response, anxiety, acute drug effects
- MeSH terms
- Adolescent, Adult, Analysis of Variance, Anxiety, Double-Blind Method, Electroshock, Fear, Female, Humans, Male, Predictive Value of Tests, Reflex, Startle, Citalopram, Selective Serotonin Reuptake Inhibitors, Cross-Over Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.